Rockville, MD, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The global hyoscine-n-butyl bromide market is valued at US$ 67.1 million in 2024 and is forecasted to expand at a CAGR of 4.6% from 2024 to 2034, as revealed in the recently updated market research report by Fact.MR, a market research and competitive intelligence provider.
More people are becoming aware of the benefits associated with the consumption of hyoscine-n-butyl bromide for the treatment of gastrointestinal disorders, which is set to widen the opportunities for market players. Growing awareness along with the adoption of non-invasive treatment options is estimated to generate demand for hyoscine-n-butyl bromide in various medications. It ensures minimal side effects and convenience without any requirements for invasive interventions.
Moreover, rising recognition of the safety and effectiveness of non-invasive treatment is contributing to increased requirements for hyoscine-n-butyl bromide, which is further anticipated to drive global market growth opportunities over the coming years.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3269
Key Takeaway from Market Study
- The market for hyoscine-n-butyl bromide is approximated to reach a valuation of US$ 105.1 million by 2034-end.
- Global demand for hyoscine-n-butyl bromide with oral administration mode is projected to increase at a CAGR of 4% and reach a value of US$ 81.3 million by the end of 2034.
- East Asia is projected to hold 6% share of global market revenue by 2034.
- Sales of hyoscine-n-butyl bromide in South Korea are forecasted to climb at 4% CAGR from 2024 to 2034.
- Demand for hyoscine-n-butyl bromide in Japan is evaluated to increase at a CAGR of 4.8% and reach a market worth of US$ 7.4 million by 2034.
“Medical conferences, educational initiatives, and promotional activities by pharmaceutical companies leading to better understanding of hyoscine-n-butyl benefits for managing gastrointestinal disorders,” says a Fact.MR analyst.
Leading Players Driving Innovation in Hyoscine-N-Butyl Bromide Market:
Some of the leading Hyoscine-N-Butyl Bromide manufacturers are Alkaloid Skopje; Caleb Pharmaceuticals Inc.; Boehringer-Ingelheim; ALPS Pharmaceutical Ind. Co. Ltd.; Linnea SA; Biotechnica Pharma Global; Alchem International; Pfizer; Nectar Lifesciences Ltd.; Baxter International Inc.
Europe to Remain Lucrative Market for Suppliers of Hyoscine-N-Butyl Bromide:
Europe is approximated to be one of the prominent global consumers of hyoscine-n-butyl bromide due to the rising population of elderly people, who are more prone to chronic gastrointestinal diseases and abdominal pain. It is finding widespread application in radiology as one of the prominent anti-spasmodic agents in the region. Hyoscine-n-butyl bromide is utilized to freeze bowel motion as one of the parts of CT and MRI studies.
Hyoscine-N-Butyl Bromide Industry News:
A few well-known producers of hyoscine-n-butyl bromide are concentrating on forming strategic alliances and partnerships in order to bolster their market share and expedite the creation of new products. They make a consistent effort to provide high-quality goods and supply chain management.
Country-specific Insights:
By 2034, the United States is predicted to control 73.5% of the North American market. Hyoscine-n-butyl bromide demand is expected to be positively impacted by favorable reimbursement regulations and a firmly built healthcare infrastructure. Furthermore, hyoscine-n-butyl bromide, one of the main substances utilized in the pharmaceutical industry, is expected to be in high demand due to the vast patient pool in the United States suffering from a variety of gastrointestinal problems.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3269
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the hyoscine-n-butyl bromide market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights into the market based on application (oral, injectables) and distribution channel (online, offline), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Checkout More Related Studies Published by Fact.MR Research:
N-Propyl Bromide Market is poised to embark on a positive growth trajectory, registering a CAGR of 2% across the forecast period (2020-2030).
Isopropyl Acetate (Ipac) Market is estimated to be valued at US$ 407.7 million in 2023 and it is expected to grow at a CAGR of 5.2% to reach US$ 676.9 million by the end of 2033.
Pharmaceutical dyes are used by pharmaceutical manufacturers to add the desired color to different types of pharmaceutical products such as tablets, pills, capsules, ointments, or syrups.
Electronics and Electrical Ceramics Market is valued to be US$ 11.6 billion in 2023 and it is anticipated to grow at a CAGR of 5.0% to reach US$ 18.9 billion by the end of 2033.
A high performance fiber, PBO (or Poly-p-phenylene-2, 6-benzobisoxazole), is a heat resistant fiber. The benzene fused oxazole ring structure is the backbone of the rigid PBO molecular chain.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Follow Us: LinkedIn | Twitter | Blog
